This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Thermo Fisher Scientific Inc (TMO)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 5.83B 851.00M 1.02B 917.10M
Receivables 1.94B 1.80B 1.81B 1.52B
Inventories 1.49B 1.44B 1.36B 1.18B
Other Current Assets 420.90M 549.30M 472.10M 318.70M
Total Current Assets 9.88B 4.83B 4.82B 4.14B
Property, Plant & Equipment, Gross 3.08B 2.85B 2.64B 2.28B
Accumulated Depreciation & Depletion 1.31B 1.13B 982.60M 867.30M
Property, Plant & Equipment, Net 1.77B 1.73B 1.66B 1.41B
Intangibles 7.07B 7.80B 7.82B 6.04B
Other Non-Current Assets 640.70M 604.40M 551.70M 494.10M
Total Non-Current Assets 21.98B 22.61B 22.01B 17.21B
Liabilities & Shareholder Equity
Total Assets 31.86B 27.44B 26.83B 21.35B
Accounts Payable 691.50M 641.40M 628.70M 551.00M
Short Term Debt 987.70M 93.10M 1.27B 105.80M
Other Current Liabilities 0.00 0.00 0.00 59.20M
Total Current Liabilities 3.13B 2.09B 3.11B 1.71B
Long Term Debt 9.50B 7.03B 5.76B 2.03B
Deferred Income Taxes 1.61B 2.05B 2.23B 1.68B
Other Non-Current Liabilities 771.80M 808.20M 696.40M 562.90M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 11.88B 9.89B 8.68B 4.28B
Total Liabilities 15.01B 11.98B 11.80B 5.99B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 16.86B 15.46B 15.04B 15.36B
Common Par 369.60M 413.50M 406.40M 401.80M
Additional Paid In Capital 8.22B 10.50B 10.15B 10.02B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 8.75B 7.70B 6.72B 5.39B
Treasury Stock -412.20M -3.00B -1.84B -490.50M
Other Equity Adjustments -77.20M -150.40M -399.50M 43.60M
Total Capitalization 26.36B 22.50B 20.79B 17.39B
Total Equity 16.86B 15.46B 15.04B 15.36B
Total Liabilities & Stock Equity 31.86B 27.44B 26.83B 21.35B
Total Common Shares Outstanding 361.96M 357.44M 371.38M 391.37M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 7.64M 56.05M 35.03M 10.41M
Basic Weighted Shares Outstanding 360.30M 363.80M 380.80M 403.30M
Diluted Weighted Shares Outstanding 365.80M 366.60M 384.80M 409.40M
Number of Employees 50000 38900 39300 37200
Number of Part-Time Employees 0 0 0 0
TMO News

TMO Thermo Fisher Scientific Inc

Analysts Ratings for TMO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 11 11
Moderate Buy 2 2 1 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

TMO Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs